Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Clozapine for Treatment-Resistant Schizophrenia
View through CrossRef
This chapter provides a summary of a landmark study on the pharmacologic management of treatment-resistant schizophrenia. This clinical trial, conducted by Kane and colleagues, asks whether clozapine is an effective option in the care of patients with treatment-resistant schizophrenia who have not responded to past trials of first-generation antipsychotics. To answer this question, the chapter reviews the basics of the study, including funding sources, study location, inclusion and exclusion criteria, number of participants, research design, interventions, follow-up, endpoints, results, criticisms, and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.
Title: Clozapine for Treatment-Resistant Schizophrenia
Description:
This chapter provides a summary of a landmark study on the pharmacologic management of treatment-resistant schizophrenia.
This clinical trial, conducted by Kane and colleagues, asks whether clozapine is an effective option in the care of patients with treatment-resistant schizophrenia who have not responded to past trials of first-generation antipsychotics.
To answer this question, the chapter reviews the basics of the study, including funding sources, study location, inclusion and exclusion criteria, number of participants, research design, interventions, follow-up, endpoints, results, criticisms, and limitations.
The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.
Related Results
Secondary Schizophrenia
Secondary Schizophrenia
Schizophrenia may not be a single disease, but the result of a diverse set of related conditions. Modern neuroscience is beginning to reveal some of the genetic and environmental u...
Emil Kraepelin
Emil Kraepelin
Emil Kraepelin, professor of psychiatry first in Heidelberg then Munich, originated modern psychiatric diagnosis. So it was a fateful error when, in 1899, Kraepelin made catatonia ...
The ontology and epistemology of symptoms: The case of auditory verbal hallucinations in schizophrenia
The ontology and epistemology of symptoms: The case of auditory verbal hallucinations in schizophrenia
We present a phenomenological account of auditory verbal hallucinations (AVH) in schizophrenia. We examine the mode of articulation of AVH, their spatial and temporal characteristi...
Interventions
Interventions
Despite the fact that suicide is one of the leading causes of death in the United States, there are currently no US Food and Drug Administration-approved treatments for suicidal be...
Eugen Bleuler
Eugen Bleuler
Eugen Bleuler, professor of psychiatry in Zurich, renamed Kraepelin’s dementia praecox as “schizophrenia” in 1908. He retained catatonia as a subtype. Bleuler’s dementia praecox wa...
Neurodevelopment and Schizophrenia
Neurodevelopment and Schizophrenia
This book was originally published in 2004 and concerns developmental neurobiology. In the decade preceding publication, developmental neurobiology made important strides towards e...
North American Prodrome Longitudinal Study
North American Prodrome Longitudinal Study
This chapter provides a summary of a landmark study on schizophrenia. The question studied was “In patients identified clinically to be at high risk for psychosis, which variables ...
Rasmussen Encephalitis
Rasmussen Encephalitis
Rasmussen encephalitis (RE) is a rare epileptic disorder that is characterized by the presence of unihemispheric seizures coinciding with inflammation. The disease mostly presents ...